427 related articles for article (PubMed ID: 32237930)
21. Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population.
Shafie AA; Vasan Thakumar A; Lim CJ; Luo N
Qual Life Res; 2019 Jan; 28(1):153-162. PubMed ID: 30317426
[TBL] [Abstract][Full Text] [Related]
22. Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis.
Lin J; Wong CKH; Cheung JPY; Cheung PWH; Luo N
Eur J Health Econ; 2022 Nov; 23(8):1383-1395. PubMed ID: 35122171
[TBL] [Abstract][Full Text] [Related]
23. Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys.
Martí-Pastor M; Pont A; Ávila M; Garin O; Vilagut G; Forero CG; Pardo Y; Tresserras R; Medina-Bustos A; Garcia-Codina O; Cabasés J; Rajmil L; Alonso J; Ferrer M
Popul Health Metr; 2018 Aug; 16(1):14. PubMed ID: 30115092
[TBL] [Abstract][Full Text] [Related]
24. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.
Golicki D; Niewada M; Karlińska A; Buczek J; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Jun; 24(6):1555-63. PubMed ID: 25425288
[TBL] [Abstract][Full Text] [Related]
25. What is the association between gender and self-perceived health status when controlling for disease-specific conditions? A retrospective data analysis of pre- and post-operative EQ-5D-5L differences in total hip and knee arthroplasty.
Bischof AY; Steinbeck V; Kuklinski D; Marques CJ; Bohlen K; Westphal KC; Lampe F; Geissler A
BMC Musculoskelet Disord; 2023 Nov; 24(1):914. PubMed ID: 38012614
[TBL] [Abstract][Full Text] [Related]
26. The EQ-5D-5L is More Discriminative Than the EQ-5D-3L in Patients with Diabetes in Singapore.
Wang P; Luo N; Tai ES; Thumboo J
Value Health Reg Issues; 2016 May; 9():57-62. PubMed ID: 27881260
[TBL] [Abstract][Full Text] [Related]
27. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.
Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K
Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788
[TBL] [Abstract][Full Text] [Related]
28. Comparing the properties of the EQ-5D-5L and EQ-5D-3L in general population in Iran.
Rezaei S; Woldemichael A; Ahmadi S; Mohamadi Bolbanabad A; Zahir Abdullah F; Piroozi B
Int J Health Plann Manage; 2021 Sep; 36(5):1613-1625. PubMed ID: 34013594
[TBL] [Abstract][Full Text] [Related]
29. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients.
Pan CW; Sun HP; Wang X; Ma Q; Xu Y; Luo N; Wang P
Qual Life Res; 2015 Jul; 24(7):1767-74. PubMed ID: 25540029
[TBL] [Abstract][Full Text] [Related]
30. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
31. EQ-5D-3L and EQ-5D-5L population norms for Thailand.
Kangwanrattanakul K; Krägeloh CU
BMC Public Health; 2024 Apr; 24(1):1108. PubMed ID: 38649833
[TBL] [Abstract][Full Text] [Related]
32. Comparing Measurement Properties of the English EQ-5D-Y 3-Level Version With the 5-Level Version in South Africa.
Verstraete J; Amien R; Scott D
Value Health Reg Issues; 2022 Jul; 30():140-147. PubMed ID: 35429927
[TBL] [Abstract][Full Text] [Related]
33. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis.
Koszorú K; Hajdu K; Brodszky V; Bató A; Gergely LH; Kovács A; Beretzky Z; Sárdy M; Szegedi A; Rencz F
Eur J Health Econ; 2023 Feb; 24(1):139-152. PubMed ID: 35412162
[TBL] [Abstract][Full Text] [Related]
34. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
[TBL] [Abstract][Full Text] [Related]
35. Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary.
Rencz F; Brodszky V; Gulácsi L; Golicki D; Ruzsa G; Pickard AS; Law EH; Péntek M
Value Health; 2020 Sep; 23(9):1235-1245. PubMed ID: 32940242
[TBL] [Abstract][Full Text] [Related]
36. A head-to-head comparison of measurement properties of the EQ-5D-3L and EQ-5D-5L in acute myeloid leukemia patients.
Yu H; Zeng X; Sui M; Liu R; Tan RL; Yang J; Huang W; Luo N
Qual Life Res; 2021 Mar; 30(3):855-866. PubMed ID: 32965633
[TBL] [Abstract][Full Text] [Related]
37. Population norms for the EQ-5D-3L and EQ-5D-5L in Romania.
Olariu E; Caplescu R; Vale L; Niculescu-Aron IG; Oluboyede Y; Paveliu MS
Health Qual Life Outcomes; 2023 Jul; 21(1):80. PubMed ID: 37507760
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the Swedish EQ-5D experience-based value sets in a total hip replacement population.
Nemes S; Burström K; Zethraeus N; Eneqvist T; Garellick G; Rolfson O
Qual Life Res; 2015 Dec; 24(12):2963-70. PubMed ID: 26038221
[TBL] [Abstract][Full Text] [Related]
39. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia.
Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F
Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138
[TBL] [Abstract][Full Text] [Related]
40. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
